PDF herunterladen
Thromb Haemost 1994; 71(03): 397-398
DOI: 10.1055/s-0038-1642449
Letter to the editor
Schattauer GmbH Stuttgart

Coagulopathy Caused by Intrauterine Dextran

P McPhedran
Yale New Haven Hospital, New Haven, CT, USA
,
D B Seifer
Yale New Haven Hospital, New Haven, CT, USA
,
L P Clyne
Yale New Haven Hospital, New Haven, CT, USA
,
D Ingbar
Yale New Haven Hospital, New Haven, CT, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 04. August 1993

Accepted after revision 16. September 1993

Publikationsdatum:
06. Juli 2018 (online)

Auch verfügbar auf
  als PDF herunterladen  Lizenzen und Reprints
 

  • References

  • 1 Bergqvist D. Dextran and haemostasis. Acta Chir Scand 1982; 148: 633-40
    PubMedGoogle Scholar
  • 2 Mangar D, Gerson JI, Constantine RM. Pulmonary edema and coagulopathy due to Hyskon® (32% Dextran 70) administration. Anesth Analg 1989; 68: 686-7
    PubMedGoogle Scholar
  • 3 Jedeikin R, Olsfanger D, Kessler I. Disseminated intravascular coagulation and adult respiratory distress syndrome - life threatening complications of hysteroscopy. Am J Obstet Gynecol 1990; 162: 44-5
    CrossrefPubMedGoogle Scholar
  • 4 Choban MJ, Kalhan SB, Anderson RH, Collins R. Pulmonary edema and coagulopathy following intrauterine instillation of 32% dextran-70 (Hyskon). J Clin Anesth 1991; 3: 317-9
    CrossrefPubMedGoogle Scholar
  • 5 Åberg M, Pausing A. The effect of dextran-70 on the structure of ex-vivo thrombi. Thromb Res 1978; 12: 1113-23
    CrossrefPubMedGoogle Scholar
  • 6 Carlin G, Saldeen T. On the interaction between dextran and the fibrinolysis inhibitor α2-antiplasmin. Thromb Res 1980; 19: 103-10
    CrossrefPubMedGoogle Scholar
  • 7 Batlle J, deRio J, López-Fernández MF, Martin R, López-Borrasca A. Effect of dextran on factor VUI/von Willebrand structure and function. Thromb Haemostas 1985; 54: 697-9
    PubMedGoogle Scholar